From Control to Care: Reframing Medication Access Policies Through Public Health Ethics

2026/01/01 by Kaitlyn Jaffe, Elizabeth Evans, Elizabeth A. Evans
Medicine · Neuroscience · #Neuroethics, Human Enhancement, Biomedical Innovations #Opioid Use Disorder Treatment #Substance Abuse Treatment and Outcomes

paper · pdf · doi:10.1017/jme.2025.10220

openalex publication_date 2026/01/01 · openalex created_date 2026/03/26 · openalex updated_date 2026/07/30

Abstract

Dantuluri examines the ongoing prescription stimulant shortage driven by the Drug Enforcement Administration's quota restrictions and an ineffective and fragmented system of drug governance. We extend this analysis to carceral health systems, which operate under similar logics of control in managing risks, diversion, and liability around medications for opioid use disorder. In drawing these parallels, we explore how perceptions of risk, suspicion, and restrictive oversight can produce scarcity, reinforce stigma, and elicit judgments around "deservingness" that may ultimately widen treatment gaps. We conclude with actionable recommendations that align with public health ethics to promote equitable access to evidence-based treatment.

Related

• Competing Issue Publics in the Opioid Epidemic: Implications for Public Policy
• “Do you deny somebody Suboxone … if they just didn’t pee in a cup for you?”: Moral dilemmas of medication treatment for opioid use disorder
• The material practices and social dimensions of community care among people who use, produce, and supply image and performance enhancing drugs
• Accessible Care: The Human Rights Case for Take-Home Injectable Opioid Agonist Treatment
• Constructing Opioid Legitimacy: The Canadian Pain Task Force’s Framing of the Overdose Crisis